Akme Fintrade Sees Credit Rating Assignments and Upgrades Across Debt Instruments
Akme Fintrade (India) Ltd reported credit ratings for its debt instruments, noting assignments and upgrades across bank loans, non-convertible debentures, and commercial paper as of April 08, 2026.The company detailed the credit rating profile for different product segments. The rating assessment covered a total outstanding quantum of Rs. 855 Cr, with zero amount reported as withdrawn.
The credit ratings are presented below:
| Product | Quantum (Rs Cr) | Long Term Rating | Short Term Rating |
|---|---|---|---|
| Bank Loan Ratings | 355 | ACUITE A- Stable Assigned | - |
| Bank Loan Ratings | 180 | ACUITE A- Stable Upgraded | - |
| Non-Convertible Debentures (NCD) | 200 | ACUITE A- Stable Assigned | - |
| Non-Convertible Debentures (NCD) | 100 | ACUITE A- Stable Upgraded | - |
| Commercial Paper (CP) | 20 | - | ACUITE A2+ Assigned |
| Total Outstanding Quantum (Rs. Cr) | 855 | - | - |
| Total Withdrawn Quantum (Rs. Cr) | 0 | - | - |
For the two tranches of Bank Loan Ratings, one quantum of Rs. 355 Cr received an ACUITE A- Stable Assigned rating for the long term. Additionally, a quantum of Rs. 180 Cr was assigned an ACUITE A- Stable Upgraded rating for the long term.
Regarding Non-Convertible Debentures (NCD), the structure with a quantum of Rs. 200 Cr was rated ACUITE A- Stable Assigned for the long term. Similarly, an NCD quantum of Rs. 100 Cr received an ACUITE A- Stable Upgraded long term rating.
For the Commercial Paper (CP) instrument, a quantum of Rs. 20 Cr was assigned a Short Term Rating of ACUITE A2+ Assigned.
AFIL Stock Price Movement
Shares of Akme Fintrade (India) Limited are edging higher to ₹9.00 as of 11:37 AM today, rebounding to gain 2.04% in live trading. The stock sustains momentum, trading on robust volume exceeding 1.05 million shares during the ongoing session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.